Grove Biopharma
Latest round
- Series A
Last raised
- Apr 2025
Total raised
- $34M
Investors
- 8
About Grove Biopharma
Grove Biopharma, Inc.Founded in 2020 and headquartered in Chicago, US, Grove Biopharma, Inc. specializes in developing innovative synthetic therapeutics.Grove Biopharma specializes in the development of Bionic Biologics™, a novel class of synthetic therapeutics designed to target intracellular protein-protein interactions (PPIs). These therapeutics are hybrid biomolecules that combine elements of biological and synthetic design, enhancing functionality beyond what is naturally achievable. The core product offerings include customizable, multivalent biomolecules that facilitate membrane permeability, enabling them to reach intracellular targets. This innovative approach is aimed at addressing critical medical needs in patients suffering from cancer, neurodegenerative diseases, and rare disorders.Grove Biopharma generates revenue through partnerships and collaborations with pharmaceutical companies, research institutions, and healthcare organizations interested in the therapeutic potential of its Bionic Biologics™ platform. Revenue transactions typically occur via formal agreements that may involve licensing fees, milestone payments, or revenue-sharing models based on the commercial success of developed therapeutics. The company’s flagship offerings operate on a contractual basis with clients who require specific therapeutic solutions tailored to complex diseases.In April 2025, Grove Biopharma, Inc. The company is set to introduce new products designed for treating complex diseases in the coming year. Furthermore, Grove Biopharma plans to expand into new markets in Europe and Asia by late 2026, aiming to increase access to its innovative therapies globally.
Who invested in Grove Biopharma
8 investors across 2 rounds
See all investors in Grove Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Grove Biopharma
Who invested in Grove Biopharma?
Grove Biopharma has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Grove Biopharma raised?
Grove Biopharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Grove Biopharma last raise money?
Grove Biopharma's most recent round on record is a Series A, in Apr 2025.
What does Grove Biopharma do?
Grove Biopharma is a biotechnology company.
Where is Grove Biopharma headquartered?
Grove Biopharma is headquartered in Chicago, US.
Which VCs invest in companies like Grove Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Grove Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Grove Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.